Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 3, 2020
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophreniaMarta Valle-León, Luis F Callado, Ester Aso, et al.
Molecular Psychiatry|August 26, 2025
Extracellular matrix dysfunction and synaptic alterations in schizophreniaPaula Unzueta-Larrinaga, Esteban Cuesta-Vega, Rocío Barrena-Barbadillo, et al.
Psychiatry Research|August 6, 2015
Semaphorin and plexin gene expression is altered in the prefrontal cortex of schizophrenia patients with and without auditory hallucinationsJavier Gilabert-Juan, Ana Rosa Sáez, Guillermo Lopez-Campos, et al.
International Journal of Molecular Sciences|February 25, 2023
The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn RatsMaría Villa, María Martínez-Vega, Aarón Del Pozo, et al.
Biomedicines|January 23, 2024
Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular ConnectomeCristina Lorca, María Fernández-Rhodes, Jose Antonio Sánchez Milán, et al.
Pediatric Research|February 15, 2024
Effects of cannabidiol in post-stroke mood disorders in neonatal ratsMaría Villa, María Martínez-Vega, Laura Silva, et al.
Brain Structure & Function|January 19, 2019
Cartography of hevin-expressing cells in the adult brain reveals prominent expression in astrocytes and parvalbumin neuronsRaphaële Mongrédien, Amaia M Erdozain, Sylvie Dumas, et al.
Translational Psychiatry|November 1, 2025
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophreniaLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Brain Structure & Function|May 8, 2024
NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophreniaCarmen Almodóvar-Payá, Maria Guardiola-Ripoll, Maria Giralt-López, et al.
Drug Design, Development and Therapy|March 5, 2014
Combining rimonabant and fentanyl in a single entity: preparation and pharmacological resultsCristina Fernández-Fernández, Luis F Callado, Rocío Girón, et al.
Pageof 13